View printer-friendly version

Download PDF

Emergent BioSolutions to Webcast Presentation at the Cowen & Co. 29th Annual Health Care Conference on Tuesday, March 17, 2009

ROCKVILLE, Md.–(BUSINESS WIRE)–Feb. 27, 2009– Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Cowen & Co. 29^th Annual Health Care Conference scheduled for Tuesday, March 17, 2009 at 10:15 am Eastern. A member of the company’s senior management team will provide a corporate overview, including a discussion of product development programs, recent corporate activities and financial performance.

A webcast of this presentation will be available both live and by replay. To access either the live or archived webcast, please proceed to www.emergentbiosolutions.com, and click on the “Investors” link the day of the presentation.

An archived replay of the webcast will be available 24 hours after the live presentation.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of immune-related biologic products, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax^® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent’s development pipeline includes programs focused on anthrax, botulism, typhoid, tuberculosis, hepatitis B and chlamydia. Additional information may be found at www.emergentbiosolutions.com.

 

 

Source: Emergent BioSolutions Inc.